THE DE PARYS GROUP — All Prescriptions & Medications — Page 11
Practice Code: E81037 | BEDFORD, MK40 2NT
Showing results 501-550 of 788
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fosfomycin trometamol | 56 | 58 | £268 | +96.8% ▲ |
| Timolol and travoprost | 56 | 223 | £833 | +73.3% ▲ |
| Glycopyrronium/formoterol | 55 | 57 | £1.8K | +117.4% ▲ |
| Codeine phosphate | 55 | 28.9K | £491 | +283.2% ▲ |
| Guanfacine | 55 | 1,358 | £3.0K | +114.1% ▲ |
| Ipratropium bromide | 55 | 60 | £423 | +239.2% ▲ |
| Calcitriol | 54 | 4,978 | £1.1K | +246.1% ▲ |
| Almotriptan | 52 | 321 | £695 | +319.5% ▲ |
| Nicotine | 52 | 4,448 | £4.8K | -7.9% ▼ |
| Varenicline tartrate | 52 | 1,436 | £1.7K | +425.3% ▲ |
| Tetrabenazine | 51 | 5,299 | £5.7K | +221.7% ▲ |
| Rifaximin | 51 | 2,975 | £13.8K | +90.0% ▲ |
| Pyridoxine hydrochloride | 51 | 2,331 | £1.2K | +137.3% ▲ |
| Ketorolac trometamol | 51 | 280 | £185 | +449.7% ▲ |
| Permethrin | 51 | 2,700 | £653 | +35.4% ▲ |
| 51 | 139 | £2.1K | +269.3% ▲ | |
| 50 | 162 | £1.3K | +293.0% ▲ | |
| Zonisamide | 48 | 4,732 | £1.8K | +10.0% ▲ |
| Acetazolamide | 48 | 4,182 | £165 | +121.5% ▲ |
| 48 | 470 | £2.3K | +134.0% ▲ | |
| Sodium feredetate | 47 | 13.9K | £398 | +64.1% ▲ |
| Betamethasone sodium phosphate | 47 | 560 | £124 | +81.4% ▲ |
| Zuclopenthixol hydrochloride | 46 | 4,600 | £325 | +45.9% ▲ |
| 46 | 365 | £138 | +58.8% ▲ | |
| Modafinil | 45 | 4,130 | £337 | +115.8% ▲ |
| Opicapone | 45 | 1,470 | £2.9K | +135.1% ▲ |
| Itraconazole | 45 | 2,573 | £1.1K | +235.4% ▲ |
| Fesoterodine fumarate | 45 | 2,170 | £185 | +14.1% ▲ |
| Zinc oxide | 45 | 9,050 | £293 | +123.8% ▲ |
| Phosphates (Rectal) | 44 | 206 | £3.2K | +260.0% ▲ |
| Pyridostigmine bromide | 44 | 9,200 | £742 | +157.1% ▲ |
| 44 | 844 | £173 | -80.0% ▼ | |
| 44 | 615 | £221 | +8.1% ▲ | |
| Ciclesonide | 43 | 52 | £1.1K | +192.1% ▲ |
| Galantamine | 43 | 1,428 | £1.6K | +13.6% ▲ |
| Other individually formulated bought in preparations | 43 | 1,226 | £332 | +31.6% ▲ |
| Betamethasone sodium phosphate | 42 | 4,033 | £541 | +241.6% ▲ |
| Azelastine hydrochloride | 42 | 1,078 | £489 | +274.7% ▲ |
| Other sunscreening preparations | 42 | 7,750 | £530 | +435.9% ▲ |
| 42 | 276 | £904 | +51.8% ▲ | |
| 42 | 520 | £469 | +253.0% ▲ | |
| Naftidrofuryl oxalate | 41 | 3,612 | £430 | +25.8% ▲ |
| Ketoprofen | 41 | 3,900 | £180 | +14.3% ▲ |
| Olmesartan medoxomil | 40 | 2,086 | £103 | -41.9% ▼ |
| Acamprosate calcium | 40 | 3,948 | £460 | +14.9% ▲ |
| Exemestane | 40 | 1,838 | £1.3K | +23.1% ▲ |
| Latanoprost and timolol | 40 | 1,023 | £635 | -47.6% ▼ |
| 40 | 1,410 | £2.5K | +394.9% ▲ | |
| Entacapone | 39 | 5,522 | £1.1K | +155.8% ▲ |
| Ofloxacin | 39 | 1,106 | £1.5K | +374.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.